Commentary
Video
In cases with optic nerve hyperfluorescence or neurologic symptoms, prompt neuroimaging is warranted to rule out neuro-Behcet disease and guide multidisciplinary management.
In this episode of NeuroOp Guru, Andrew G. Lee, MD, and Andrew Carey, MD, discuss the overlap between Behcet uveitis and neurologic involvement in Behcet disease, emphasizing the importance of coordinated care between uveitis and neuro-ophthalmology specialists. Behcet is a multisystem autoimmune disease that commonly affects the skin, vasculature, GI tract, and eyes. While uveitis is a hallmark finding, neuro-Behcet—though less common—is potentially life-threatening.
A retrospective review1 discussed in the episode examined whether ocular signs and symptoms could predict CNS involvement. Key clinical red flags included persistent headaches (especially with meningeal signs), seizures, cranial nerve deficits (eg, diplopia, facial palsy), and optic neuritis. Less common were motor and cerebellar signs; sensory or cognitive symptoms were rare.
Importantly, even in the absence of overt neurologic symptoms, optic disc staining and leakage on fluorescein angiography increased the odds of neuro-Behcet (OR 5.4). This suggests that subtle optic nerve involvement seen during uveitis evaluation should prompt MRI consideration.
However, routine MRI for all patients with Behcet disease is discouraged due to the rarity of neuro involvement, imaging delays, and risks of incidental findings. Instead, imaging should be reserved for patients with neurologic symptoms, optic nerve signs, or high-risk fluorescein findings.
MRI findings may include venous sinus thrombosis, pachymeningitis, parenchymal enhancement, or white matter lesions mimicking multiple sclerosis. Enhancing or large white matter lesions are more concerning than age-related, non-enhancing changes.
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.